The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20

European Journal of Cancer

Volumn 41, Issue 8, 2005, Pages 1135-1139

  Postma, T J ^a   Aaronson, N K ^b   Heimans, J J ^a   Muller, M J ^b   Hildebrand, J G ^c   Delattre, J Y ^d   Hoang Xuan, K ^d   Lanteri Minet M ^e   Grant, R ^f   Huddart, R ^g   Moynihan, C ^g   Maher, J ^h   Lucey, R ^h  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ERASME HOSPITAL   (Belgium)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e PASTEUR HOSPITAL   (France)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; EORTC; Peripheral neuropathy; QLQ CIPN20; Quality of life questionnaire

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; OXALIPLATIN; PACLITAXEL; VINBLASTINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CHEMOTHERAPY; HEALTH CARE ORGANIZATION; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NURSE; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SELF REPORT;

EID: 21144457498     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.02.012     Document Type: Article

References (19)

1. M. Markman Chemotherapy-associated neurotoxicity: an important side effect-impacting on quality, rather than quantity, of life J Cancer Res Clin Oncol 122 1996 511 512
2. L. Wenzel, I. Vergote, and D. Cella Quality of life in patients receiving treatment for gynaecologic malignancies: special considerations for patient care Int J Gynaecol Obstet 83 Suppl. 1 2003 211 229
3. T.J. Postma, and J.J. Heimans Grading of chemotherapy-induced peripheral neuropathy Ann Oncol 11 2000 509 513
4. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
5. D.F. Cella, D.S. Tulsky, and G. Gray The functional assessment of cancer therapy scale: Development and validation of the general measure J Clin Oncol 11 1993 570 579
6. E.A. Calhoun, E.E. Welshman, and C.-H. Chang Psychometric evaluation of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (Fact/GOG-NTx) questionnaire for patients receiving systemic chemotherapy Int J Gynecol Cancer 13 2003 741 748
7. D. Cella, A. Peterman, and S. Hudgens Measuring the side effects of taxane therapy in oncology. The functional assessment of cancer therapy-Taxane (FACT-Taxane) Cancer 98 2003 822 831
8. M.A.G. Sprangers, A. Cull, and M. Groenvold The European organization for research and treatment of cancer approach to developing questionnaire modules: an update and overview Qual Life Res 7 1998 291 300
9. V. Chaudhry, E.K. Rowinsky, and S.E. Sartorius Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies Ann Neurol 35 1994 304 311
10. A.B. Miller, B. Hoogstraten, and M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
11. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the eastern cooperative oncology group Am J Clin Oncol 5 1982 649 655
12. J.A. Ajani, S.R. Welch, and M.N. Raber Comprehensive criteria for assessing therapy-induced toxicity Cancer Invest 8 1990 147 159
13. K. Vantongelen A practical guide to EORTC studies 1994 EORTC Central Office-Data Center Brussels
14. P.J. Dyck, W.R. Sherman, and L.M. Hallcher Human diabetic endoneurial sorbitol, fructose and myo-inositol related to sural nerve morphometry Ann Neurol 8 1980 590 596
15. P.J. Dyck, J. Karnes, and P.C. O'Brien Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy and amyloidosis Neurology 36 1986 1300 1308
16. P.J. Dyck, J.L. Davies, and W.J. Litchy Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester diabetic neuropathy study cohort Neurology 49 1997 229 239
17. G. Cavaletti, G. Bogliun, and L. Marzorati Grading of chemotherapy-induced peripheral neurotoxicity using the total neuropathy scale Neurology 61 2003 1297 1300
18. P.A. Grootenhuis, F.J. Snoek, and R.J. Heine Development of a type 2 diabetes symptom checklist: a measure of symptom severity Diabet Med 11 1994 253 261
19. Cull A, Sprangers M, Bjordal K, et al. EORTC quality of life study group translation procedure. Internal Report. Brussels, EORTC, 1998